Roche’s oral SMA med Evrysdi turned down by U.K. cost watchdog—despite prior nods for Zolgensma and Spinraza June 3, 2021 Auto Bot News 0 Roche’s oral SMA med Evrysdi turned down by U.K. cost watchdog—despite prior nods for Zolgensma and Spinraza nhigginsdunn Thu, 06/03/2021 – 11:39
